IRTC

142.78

2.17% -3.17

Dopo l'orario di chiusura: 142.78

Irhythm Technologies Inc (IRTC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$145.95

Aprire:

$145.41

Volume 24 ore:

630.29K

Relative Volume:

1.35

Capitalizzazione di mercato:

$4.74B

Reddito:

$560.03M

Utile/perdita netta:

$-150.66M

Rapporto P/E:

-29.38

EPS:

-4.86

Flusso di cassa netto:

$-87.43M

1 W Prestazione:

-5.74%

1M Prestazione:

+1.51%

6M Prestazione:

+59.64%

1 anno Prestazione:

+44.79%

Intervallo 1D:

$141.79

$146.88

Intervallo di 1 settimana:

$141.79

$157.13

Portata 52W:

$55.92

$157.13

Irhythm Technologies Inc Stock (IRTC) Company Profile

Nome

Irhythm Technologies Inc

Settore

Healthcare (1166)

Industria

Medical Devices (148)

Telefono

415-632-5700

Indirizzo

699 8TH STREET, San Francisco, CA

Dipendente

2,000

Cinguettio

@iRhythmTech

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

IRTC's Discussions on Twitter

Confronta IRTC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IRTC Irhythm Technologies Inc	142.78	4.74B	560.03M	-150.66M	-87.43M	-4.86
ABT Abbott Laboratories	134.11	233.36B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	103.63	147.06B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	391.81	145.64B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	88.28	112.76B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	77.02	44.46B	5.54B	4.18B	623.10M	7.00

Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-05-02	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-12-03	Ripresa	Wells Fargo	Equal Weight
2024-10-04	Iniziato	Goldman	Neutral
2024-06-20	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2023-12-11	Aggiornamento	Citigroup	Neutral → Buy
2023-07-19	Iniziato	Robert W. Baird	Outperform
2023-02-07	Iniziato	Wells Fargo	Overweight
2022-11-07	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2022-06-09	Downgrade	Citigroup	Buy → Neutral
2022-04-06	Iniziato	Wolfe Research	Underperform
2022-02-24	Aggiornamento	Needham	Hold → Buy
2022-01-18	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2022-01-12	Aggiornamento	BTIG Research	Neutral → Buy
2022-01-11	Aggiornamento	Oppenheimer	Perform → Outperform
2021-12-21	Ripresa	Canaccord Genuity	Buy
2021-12-17	Aggiornamento	JP Morgan	Neutral → Overweight
2021-12-15	Aggiornamento	Citigroup	Neutral → Buy
2021-06-02	Downgrade	Citigroup	Buy → Neutral
2021-04-13	Downgrade	BTIG Research	Buy → Neutral
2021-04-12	Downgrade	JP Morgan	Overweight → Neutral
2021-02-26	Downgrade	Colliers Securities	Buy → Neutral
2021-01-29	Reiterato	Needham	Hold
2020-11-17	Downgrade	Oppenheimer	Outperform → Perform
2020-09-11	Iniziato	Needham	Hold
2020-09-02	Iniziato	Robert W. Baird	Neutral
2020-08-07	Aggiornamento	Colliers Securities	Neutral → Buy
2020-08-05	Aggiornamento	Oppenheimer	Perform → Outperform
2020-03-05	Iniziato	Citigroup	Buy
2020-02-06	Iniziato	BTIG Research	Buy
2020-01-10	Iniziato	William Blair	Outperform
2020-01-08	Iniziato	SunTrust	Buy
2019-10-22	Iniziato	Oppenheimer	Perform
2019-02-20	Downgrade	Chardan Capital Markets	Buy → Neutral
2018-09-13	Reiterato	Canaccord Genuity	Buy
2018-09-06	Iniziato	Chardan Capital Markets	Buy
2018-08-02	Aggiornamento	Dougherty & Company	Sell → Neutral
2018-07-16	Downgrade	Dougherty & Company	Neutral → Sell
2017-12-01	Iniziato	Dougherty & Company	Neutral

Mostra tutto

Irhythm Technologies Inc Borsa (IRTC) Ultime notizie

Jun 18, 2025

SHAREHOLDER ALERT: Morris Kandinov Investigating IRTC, - GlobeNewswire

Jun 18, 2025

Jun 17, 2025

Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the - Bluefield Daily Telegraph

Jun 17, 2025

Robbins LLP Informs iRhythm Technologies, Inc. (IRTC) Investors That the Class Action Beat the Motion to Dismiss - GlobeNewswire

Jun 17, 2025

iRhythm at 2025 Truist Securities MedTech Conference: Strategic Growth Plans - Investing.com

Jun 17, 2025

Discretionary Denials in Action: iRhythm Technologies Inc. v. Welch Allyn Inc. | ProskauerThe Patent Playbook - JD Supra

Jun 17, 2025

File Early or Risk Denial: iRhythm IPR Institution Denial Underscores the Importance of Filing IPR Petitions Sooner Rather Than Later | Regulatory Roundup | Insights - Vinson & Elkins LLP

Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 17, 2025

Cardiovascular Digital Solutions Market Generated - openPR.com

Jun 17, 2025

GAMMA Investing LLC Acquires 8,660 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World

Jun 17, 2025

Jun 16, 2025

iRhythm Creates a New Basis for Discretionary Denial - IPWatchdog.com

Jun 16, 2025

Jun 15, 2025

(IRTC) Investment Report - news.stocktradersdaily.com

Jun 15, 2025

Jun 14, 2025

Rhumbline Advisers Has $4.81 Million Stake in iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World

Jun 14, 2025

Jun 13, 2025

iRhythm Technologies (NASDAQ:IRTC) shareholders have earned a 57% return over the last year - Yahoo Finance

Jun 13, 2025

iRhythm Technologies, Inc. (NASDAQ:IRTC) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World

Jun 13, 2025

Jun 12, 2025

iRhythm: Promising OutlookSo Long As Past Mistakes Are Not Repeated (NASDAQ:IRTC) - Seeking Alpha

Jun 12, 2025